IPO Guru
Bajaj
Listed Mainboard

Dr. Lal PathLabs IPO Subscription Status

Dr. Lal PathLabs IPO was subscribed 33.41 times when bidding closed on 10 Dec 2015: QIB 63.56x, NII 61.28x, Retail 4.24x.

The Dr. Lal PathLabs IPO has been subscribed 33.41x times overall. Retail investors have shown interest with bids for 4.24x the shares available. The Non-Institutional Investor (NII) category has been subscribed 61.28x. Qualified Institutional Buyers (QIBs) have subscribed 63.56x. Data last updated on 12 Nov, 03:10 PM.

The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 08 Dec, 2015 and closes on 10 Dec, 2015. The shares are expected to list on stock exchanges on 23 Dec, 2015.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Live bidding

Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.

Last updated 12 Nov 2026, 03:10 PM
Category Bid details Times
QIB - of - - 63.56x
NII - of - - 61.28x
Retail - of - - 4.24x
TOTAL - - 33.41x
Advertisement

Dr. Lal PathLabs IPO allotment probability

Your odds of an allotment in each category at the current subscription.

Retail (up to ₹2 L)
1 out of 4
~23.6% chance per PAN — based on 4.24x subscription. Winners get exactly 1 lot (₹11,000) by SEBI lottery, however many lots you bid.
NII / HNI (above ₹2 L)
1 out of 61
~1.6% chance — lottery allots the minimum application per winner (SEBI NII rule since 2022).
QIB (institutions)
63.56x
Proportionate allotment — at 63.56x, institutions receive ~1.6% of their bid. No lottery; not open to individual investors. Strong institutional endorsement.

Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.

Subscription insights

What the current book is saying, read off the category numbers above.

Retail Allotment

Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 23.6% for a single lot.

Institutional Backing

Massive institutional interest with QIBs subscribing 63.56x. This often signals long-term confidence from professional funds.

Day-wise subscription history

End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.

Date Total
10 Dec 2015
Day 3
33.41x ▼
QIB63.56x BHNI- SHNI- Retail4.24x
09 Dec 2015
Day 2
2.64x ▼
QIB- BHNI- SHNI- Retail-
08 Dec 2015
Day 1
0.65x ▼
QIB- BHNI- SHNI- Retail-

Dr. Lal PathLabs IPO dates

From the bidding window to listing. Today is 15 November.

Key dates Listed
  1. Open 08 Dec 2015
  2. Close 10 Dec 2015
  3. Allotment 19 Dec 2015
  4. Refund/credit TBA
  5. Listing 23 Dec 2015

Anchor investor allocation

Shares allotted to anchor investors the working day before the issue opened.

Anchor Investor Amt (₹ cr.) % Allocated
MERRILL LYNCH CAPITAL MARKETS ESPANA S.A.,S.V ₹33.65 Cr 17.58%
DB INTERNATIONAL ASIA LTD ₹31.50 Cr 16.46%
MORGAN STANLEY MAURITIUS COMPANY LIMITED ₹10.75 Cr 5.62%
FIDELITY INVESTMENT TRUST FIDELITY INTERNATIONAL DISCOVERY FUND ₹10.10 Cr 5.28%
T ROWE PRICE INTERNATIONAL DISCOVERY FUND ₹10.10 Cr 5.28%
FIRST STATE INVESTMENTS (HONG KONG) LIMITED FIRST STATE INDIAN SUBCONTINENT FUND ₹10.10 Cr 5.28%
JPMORGAN INDIA SMALLER COMPANIES FUND ₹10.10 Cr 5.28%
WASATCH EMERGING INDIA FUND ₹10.10 Cr 5.28%
DSP BLACKROCK SMALL AND MIDCAP FUND ₹10.00 Cr 5.22%
ICICI PRUDENTIAL TOP 100 FUND ₹10.00 Cr 5.22%
RELIANCE CAPITAL TRUSTEE CO. LTD A/C RELIANCE PHARMA FUND ₹10.00 Cr 5.22%
SBI MAGNUM MULTICAP FUND ₹5.20 Cr 2.72%
RELIANCE LIFE INSURANCE CO LTD ₹4.16 Cr 2.18%
KOTAK OPPORTUNITIES ₹4.00 Cr 2.09%
SBI MAGNUM MIDCAP FUND ₹4.00 Cr 2.09%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LTD A/C BIRLA SUN LIFE INDIA GENNEXT ₹2.50 Cr 1.31%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LTD A/C BIRLA SUN LIFE EMERGING LEADERS FUND - SERIES 2 ₹2.50 Cr 1.31%
KOTAK MAHINDRA 50 UNIT SCHEME ₹2.50 Cr 1.31%
KOTAK MIDCAP ₹2.50 Cr 1.31%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LTD A/C BIRLA SUN LIFE EMERGING LEADERS FUND - SERIES 3 ₹1.63 Cr 0.85%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LTD A/C BIRLA SUN LIFE ADVANTAGE ₹1.25 Cr 0.65%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LTD A/C INDIA ADVANTAGE (OFFSHORE) FUND ₹1.25 Cr 0.65%
KOTAK CLASSIC EQUITY ₹1.00 Cr 0.52%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LTD A/C BIRLA SUN LIFE EMERGING LEADERS FUND - SERIES 4 ₹0.87 Cr 0.46%
RELIANCE LIFE INSURANCE CO LTD SHAREHOLDERS BEYOND SOLVENCY MARGIN ₹0.84 Cr 0.44%
SBI RESURGENT INDIA OPPORTUNITIES SCHEME ₹0.80 Cr 0.42%
TOTAL ₹191.40 Cr 100.03%
View allotment letter PDF →

What does this subscription data mean?

IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:

  • 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
  • 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
  • 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
  • 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.

Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.

Frequently asked

What is the current subscription status of Dr. Lal PathLabs IPO?

As of IPO close date (10 Dec, 2015), the Dr. Lal PathLabs IPO is subscribed 33.41x times. Retail category is 4.24x, and NII is 61.28x subscribed.

When is the allotment date for Dr. Lal PathLabs IPO?

The allotment for Dr. Lal PathLabs IPO is expected to be finalized on 19 December, 2015.

When will Dr. Lal PathLabs IPO list on the stock market?

Dr. Lal PathLabs is scheduled to list on BSE and NSE on 23 December, 2015.

What are the chances of getting allotment in Dr. Lal PathLabs IPO?

The retail category is oversubscribed at 4.24x, meaning allotment is by lottery. Statistically, approximately 1 in 5 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.

What does QIB subscription of 63.56x mean for Dr. Lal PathLabs IPO?

Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 63.56x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.

How to check Dr. Lal PathLabs IPO allotment status?

After the allotment date (19 Dec, 2015), you can check your Dr. Lal PathLabs IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.

Explore Dr. Lal PathLabs IPO further

Track every stage of this IPO, from subscription to listing.

IPO Guru App
IPO Guru on Android

Subscription moves by the hour. Get it on your phone.

Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.

Get it on Google Play Join the WhatsApp channel

Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.

Total
33.41x
QIB
63.56x
NII
61.28x
Retail
4.24x
Full IPO details
Advertisement